Lastest Insider Transactions Of Arcutis Biotherapeutics, Inc. ( ARQT ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | 2024-03-04 | Sell | 3,760 | 11.12 | 41,816 | 2024-03-06 17:14:54 |
ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | 2024-03-04 | Sell | 4,782 | 11.12 | 53,182 | 2024-03-06 17:12:27 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2024-03-04 | Sell | 14,903 | 11.12 | 165,739 | 2024-03-06 17:09:59 |
ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | SVP and Chief Business Officer | 2024-03-04 | Sell | 3,468 | 11.12 | 38,568 | 2024-03-06 17:08:24 |
ARQT | Arcutis Biotherapeutics, Inc. | Heron Patrick J | Directior | 2024-03-04 | Buy | 21,052 | 9.50 | 199,994 | 2024-03-06 16:28:21 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2024-02-28 | Sell | 2,465 | 10.60 | 26,129 | 2024-03-01 16:11:02 |
ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | 2024-01-02 | Sell | 1,325 | 3.54 | 4,692 | 2024-01-03 17:30:56 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2023-05-31 | Buy | 1,463 | 6.38 | 9,334 | 2023-12-01 20:51:36 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2023-05-31 | Option Exercise | 59,525 | 1.68 | 100,038 | 2023-12-01 20:51:36 |
ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | 2023-11-18 | Sell | 1,850 | 1.98 | 3,661 | 2023-11-21 17:47:43 |
ARQT | Arcutis Biotherapeutics, Inc. | Frazier Life Sciences VIII, L.P. | 10% Owner | 2023-10-24 | Buy | 80,000 | 2.50 | 200,000 | 2023-10-26 16:09:29 |
ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | 2023-08-18 | Sell | 1,605 | 7.04 | 11,302 | 2023-08-22 12:24:31 |
ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remark | 2023-05-27 | Sell | 1,830 | 7.80 | 14,278 | 2023-06-02 20:31:18 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-04-17 | Sell | 8,500 | 13.97 | 118,728 | 2023-04-18 19:00:44 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-04-17 | Option Exercise | 8,500 | 1.68 | 14,285 | 2023-04-18 19:00:44 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-04-06 | Sell | 8,500 | 12.01 | 102,085 | 2023-04-10 16:13:14 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-04-06 | Option Exercise | 8,500 | 1.68 | 14,285 | 2023-04-10 16:13:14 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2023-03-06 | Sell | 2,435 | 15.26 | 37,167 | 2023-03-08 16:29:57 |
ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | 2023-03-06 | Sell | 291 | 15.26 | 4,442 | 2023-03-08 16:29:15 |
ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | 2023-03-06 | Sell | 851 | 15.26 | 12,989 | 2023-03-08 16:28:28 |
ARQT | Arcutis Biotherapeutics, Inc. | Turney Patricia A. | SVP, Operations | 2023-03-06 | Sell | 831 | 15.26 | 12,684 | 2023-03-08 16:26:49 |
ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Officer | 2023-03-06 | Sell | 690 | 15.26 | 10,532 | 2023-03-08 16:26:13 |
ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Officer | 2023-03-06 | Sell | 831 | 15.26 | 12,684 | 2023-03-08 16:25:29 |
ARQT | Arcutis Biotherapeutics, Inc. | Moore Matthew Richard | See Remarks | 2023-03-02 | Sell | 1,610 | 15.83 | 25,481 | 2023-03-06 18:54:26 |
ARQT | Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | 2023-03-02 | Sell | 1,434 | 15.83 | 22,696 | 2023-03-06 18:52:55 |
ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | 2023-03-02 | Sell | 1,751 | 15.83 | 27,713 | 2023-03-06 18:51:46 |
ARQT | Arcutis Biotherapeutics, Inc. | Turney Patricia A. | SVP, Operations | 2023-02-28 | Sell | 2,368 | 15.96 | 37,796 | 2023-03-02 19:07:43 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2023-02-28 | Sell | 7,815 | 15.93 | 124,483 | 2023-03-02 19:06:40 |
ARQT | Arcutis Biotherapeutics, Inc. | Burrows Scott L | Chief Financial Officer | 2023-02-28 | Sell | 1,850 | 15.90 | 29,421 | 2023-03-02 19:05:53 |
ARQT | Arcutis Biotherapeutics, Inc. | Lock Kenneth A. | Chief Commercial Officer | 2023-02-28 | Sell | 2,368 | 15.96 | 37,796 | 2023-03-02 19:04:46 |
ARQT | Arcutis Biotherapeutics, Inc. | OSBORNE DAVID W | Chief Technical Officer | 2023-02-28 | Sell | 2,005 | 15.96 | 32,002 | 2023-03-02 19:03:55 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-02-15 | Sell | 8,500 | 16.98 | 144,352 | 2023-02-21 07:20:56 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-02-15 | Option Exercise | 8,500 | 1.68 | 14,285 | 2023-02-21 07:20:56 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2023-02-13 | Sell | 1,000 | 17.01 | 17,012 | 2023-02-15 19:09:01 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2023-02-01 | Sell | 1,000 | 17.00 | 17,003 | 2023-02-03 16:26:04 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-01-17 | Sell | 8,500 | 13.72 | 116,655 | 2023-01-18 20:18:25 |
ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Directior | 2023-01-17 | Option Exercise | 8,500 | 1.68 | 14,280 | 2023-01-18 20:18:25 |
ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | 2023-01-03 | Sell | 1,475 | 15.01 | 22,136 | 2023-01-04 17:15:26 |
ARQT | Arcutis Biotherapeutics, Inc. | Watanabe Todd Franklin | See Remarks | 2022-12-07 | Sell | 1,000 | 17.06 | 17,060 | 2022-12-09 16:47:32 |